GlaxoSmithKline is notifying healthcare professionals and patients that
Arixtra (fondaparinux sodium) Starter Kits may contain
recalled Triad Group alcohol prep pads. This recall does not affect or involve actual
Arixtra. The Starter Kits do not contain
Arixtra; they only contain dosing instructions, an education booklet, a needle box, and alcohol prep pads to wipe the injection site. Any Triad alcohol prep found in these kits should not be used.
For more information visit
www.fda.gov/Safety/Recalls/ucm239219.htm.